Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790040 | Urologic Oncology: Seminars and Original Investigations | 2018 | 7 Pages |
Abstract
Patients who undergo MRI/US targeted biopsy are more likely to choose active surveillance over early definitive treatment compared to men diagnosed on systematic biopsy when adjusting for tumor grade, PSA density, prior biopsy history, race, and provider.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jennifer B. M.D., Benjamin M.D., Sejong Ph.D., Jeffrey W. M.D., Soroush M.D.,